Could Bulls Dominate Injective (INJ) Price as It Trades in a Range?

• The Injective (INJ) price stayed in the downside trajectory and looked bearish.
• The token price has not succeeded in breaching the 200-day EMA hurdle.

The Injective (INJ) price traded in a downtrend and was in a narrow range throughout the month. 

It tried to surpass the 100-day EMA mark resistance zone near $30 for weeks but failed and capped in a range.

Amidst the market recovery, the token price did not replicate any significant bounce, which justified the decline in investor buying interest.

At press time, the Injective (INJ) price traded at $25.30 with an intraday drop of 1.69%, reflecting range-bound moves on the charts. It has a monthly return ratio of -1.20% and a yearly return ratio of 236.30%.

Analyst Crypto Tony says in a tweet that buyers need to cross the $31 mark to break the range for a sharp up move; below that, the token may continue to consolidate.

Source: X

The pair of INJ/BTC is at 0.000382 BTC, and the market cap is $2.44 Billion. Analysts are neutral and suggest that the INJ price may register a range breakout, reflecting a bounce ahead.

A Key Indicator Flashes Buy Signal; What’s Next?

In a tweet, @Ali Martinez says that the past signals of TD sequential on the weekly charts had an impressive bull run over 700% and 500%, signaling yet another buy signal. 

It signals the possibility of a sharp range breakout, and the token might repeat history.

Source: X

Additionally, the token has been in a downtrend and has made a base around $20, which is the strong demand zone. Until the mark was not breached, any major sell-off could not be seen again.

Source: Santiment

Amidst the range-bound moves, the trading volume remained flat and dropped over 2.30% to $114.06 Million in the last 24 hrs.

Notably, the token ranked at 54 per the market cap and has a total supply value of 100 million.

The Relative Strength Index (RSI) curve stays near the midline region and reveals a convergence of the signal line with the RSI line.

Development Activity Massively Shot Up; Could It Lead to a Price Breakout?

Per the Sanitment data, the development activity data sharply spiked over 42% to the 46 mark, revealing the possibility of an upcoming price surge and highlighting a positive outlook.

Source: Santiment

Meanwhile, the token reveals a decline in popularity on social platforms, as the social dominance data remained flat below the midline region, directing underperformance.

The immediate support levels for the Injective (INJ) are $23 and $20, whereas the key upside hurdle is around $28, followed by $30

Could Injective Price Succeed in Escaping the $30 Mark?

The token price has traded in a narrow range for weeks, and buyers struggled to breach the range hurdle of $30. However, the key metrics and analysts have shown positive guidance that the token might reveal a bounce soon.

Disclaimer

This article is for informational purposes only and provides no financial, investment, or other advice. The author or any people mentioned in this article are not responsible for any financial loss that may occur from investing in or trading. Please do your research before making any financial decisions.

Dr. Naveen Singh

Dr. Naveen Singh is an entrepreneur with achievements in sports, academics, healthcare, innovation, blockchain technology, telecommunications, and philanthropy. He is the Co-Founder and Chief Executive Officer (CEO) of Inery, the first layer-1 blockchain programmed for database management. With Inery, he aligns with his vision of a new paradigm for data to empower web3 and complete decentralization.